Get started
Work

1418P Impact of TTFields therapy on global and functional health-related quality of life (HRQoL) in metastatic non-small cell lung cancer (mNSCLC) from the pivotal LUNAR study

Year: 2023
Type: article
DOI: 10.1016/j.annonc.2023.09.2449
Authors: R. Kotecha, T.A. Leal, R. Raumlau, L. Zhang, J. Milanowski, M. Cobo Dols, J. Roubec, L.B. Petruzelka, L. Havel, S. Kalmadi, J.P. Ward, Z.G. Andric, T. Berghmans, G. Kloecker, R. Panikkar, J.G. Aerts, M. Pless, R. Greil, W. Akerley, C.J. Langer
Institutions: Baptist Health South Florida, Winship Cancer Institute, Poznan University of Medical Sciences, Sun Yat-sen University Cancer Center, Medical University of Lublin, Hospital Clínico Universitario Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga, General University Hospital in Prague, Thomayer University Hospital, Washington University in St. Louis, University Hospital Medical Center Bezanijska kosa, Université Libre de Bruxelles, Institut Jules Bordet, University of Louisville, Geisinger Medical Center, Erasmus MC, Erasmus MC Cancer Institute, Kantonsspital Winterthur, Paracelsus Medical University, Huntsman Cancer Institute, Abramson Cancer Center, University of Pennsylvania
Language: English
Field: Medicine
Open Access status: bronze
Funders: Amgen, Eli Lilly and Company, Pfizer, AstraZeneca, Medtronic, Regeneron Pharmaceuticals, Exelixis, Jazz Pharmaceuticals, Elekta, Novocure, Accuray, ViewRay, Castle Biosciences, Daiichi-Sankyo, Eisai, Genentech, EMD Serono, Janssen Pharmaceuticals, Daiichi Sankyo Europe
OpenAlex ID: W4387810608
FWCI:
Cites:
Cited by:
Related to: 10